BMS 6077 (Metaglip 2.5 mg / 500 mg)
Generic Name: glipizide/metformin
Pill imprint BMS 6077 has been identified as Metaglip 2.5 mg / 500 mg.
Metaglip is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metaglip 2.5 mg / 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for BMS 6077 (Metaglip 2.5 mg / 500 mg)
- Generic Name:
- 2.5 mg / 500 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Bristol-Myers Squibb
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|54868-5399||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.